Nitrous oxide controls the DCN to VTA dopamine circuit by enhancing AMPA receptor functions during rewarding behavior.
Fukang Zhang, Shuyuan Fan, Shiqi Li, Yixin Xu, Yuxu Ren, Yujing Wang, Xuan Liu, Wei Ma, Jianchen Zhang, Feng Ding, Fangyuan Yin, Li Zhou, Shanwu Feng, Jie Sun, Tengfei Ma
Molecular Psychiatry May 13, 2026 DOI: 10.1038/s41380-026-03647-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical experimental study Peer reviewed |
|---|---|
| Population | Rodents |
| Intervention | Chemogenetic inhibition |
| Dose | 60% N2O, 30% N2O |
| Measures | Conditioned place preference (CPP) |
| Key findings | Exposure to 60% nitrous oxide enhances glutamatergic transmission in the DCN-VTA circuit, and inhibiting this circuit reduces N2O-induced reward behavior. |
Abstract
Nitrous oxide (N2O) is a frequently used recreational drug with significant addictive potential. The ventral tegmental area (VTA) is a key brain region associated with the rewarding effects of drugs of abuse. However, how N2O influences VTA functions to mediate reward-related behavior remains poorly understood. We reported that exposure to 60% N2O, but not 30%, effectively induced conditioned place preference (CPP) reward behavior and simultaneously increased the excitability and glutamatergic transmission of VTA dopamine neurons. Furthermore, we depicted upstream brain regions that send afferent inputs to the VTA and observed that N2O specifically elevated homocysteine levels in the deep cerebellar nuclei (DCN). Interestingly, pharmacological inhibition of homocysteine production did not significantly reduce N2O-induced rewarding behavior or the glutamatergic transmission to VTA neurons. Instead, despite being an NMDA receptor antagonist, N2O directly enhanced the AMPA receptor-mediated glutamatergic transmission and functionally increased the activity of both DCN and VTA dopamine neurons. Both the optogenetic induction of long-term depression (LTD) in the DCN-VTA neural circuit and the chemogenetic inhibition of VTA dopamine neurons attenuated N2O-induced CPP. Taken together, our findings suggest that attenuating N2O-induced potentiation of the DCN-VTA circuit may provide a novel therapeutic strategy for treating N2O-related reward behavior.
Citations in the library
Cites 4
- Nitrous Oxide Abuse: Clinical Outcomes, Pharmacology, Pharmacokinetics, Toxicity and Impact on Metabolism. Toxics November 28, 2023
- Vitamin B12 Status in Recreational Users of Nitrous Oxide: A Systematic Review Focusing on the Prevalence of Laboratory Abnormalities Antioxidants May 31, 2023
- Rewarding Subjective Effects of the NMDAR Antagonist Nitrous Oxide (Laughing Gas) Are Moderated by Impulsivity and Depressive Symptoms in Healthy Volunteers. The International Journal of Neuropsychopharmacology July 23, 2021
- Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry Current Drug Research Reviews June 1, 2019